Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors-Reference-Cited by-同舟云学术

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

Published:1998-07-21 Issue:15 Volume:95 Page:8864-8868
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Lamharzi N.,Schally A. V.,Koppan M.,Groot K.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference42 articles.

1. Cancer statistics, 1996

2. Somatostatin receptors in human prostate and prostate cancer

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth Hormone-Releasing Hormone as Potential Diagnostic and Therapeutic Target in Colorectal Cancer;Current Cancer Therapy Reviews;2024-03-12

2. Growth-hormone-releasing Hormone as a Prognostic Biomarker and Therapeutic Target in Gastrointestinal Cancer;Current Cancer Drug Targets;2023-05

3. Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: Novel Therapeutic Approaches;Molecules;2022-04-21

4. Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway;Reproductive Biology and Endocrinology;2010-05-28

5. Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival;BMC Cancer;2010-02-23